Kaiser Permanente

Pharmacists on the Front Line in Treating Cardiac Disease
Pharmacists on the Front Line in Treating Cardiac DiseaseWhen it comes to cardiac disease, pharmacists in all practice settings can make a difference.
Are Antibiotic Stewardship Programs Worth It?
Are Antibiotic Stewardship Programs Worth It?There's been a lot of talk about these programs, so just what are they accomplishing?
Here’s a more effective way to test for HPVA Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.
Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Four priorities your health plan must embrace to thrive in the future
Four priorities your health plan must embrace to thrive in the futureHealth plans of the future will focus on consumers: designing products, care and services to support improved health.
Remember When: Mail-order pharmacy appeared to be losing momentum
Remember When: Mail-order pharmacy appeared to be losing momentumOn July 20, 1992, a Drug Topics cover story posed the question, “Is Mail Order bombing?”
First statewide universal coverage: Can it happen?Colorado could have the first statewide universal healthcare system in the country if proposed legislation passes in November. Will it happen? Experts weigh in.
Risk analysis finds good safety for bilateral, same-day cataract surgeryA review of bilateral, same-day cataract surgery cases performed over a 5-year period at Kaiser Permanente centers in California identified a very low rate of complications, said Neal H. Shorstein, MD.
Kaiser Permanente wins grant to compare surveillance methods of smokersThe Patient Centered Outcomes Research Institute has awarded Kaiser Permanente $14.4 million to compare strategies for active surveillance of current and former smokers to scan for potentially cancerous small growths in the lungs, including more versus less intensive strategies.
Diabetic non-smokers taking metformin have lower lung cancer riskDiabetic non-smokers taking metformin have a lower lung cancer risk compared with those who do not take metformin, according to a study published in Cancer Prevention Research.